The T lymphocyte glycoprotein CD2 binds the cell surface ligand LFA-3

Nature ◽  
1987 ◽  
Vol 326 (6111) ◽  
pp. 400-403 ◽  
Author(s):  
Periasamy Selvaraj ◽  
Marian L. Plunkett ◽  
Michael Dustin ◽  
Martin E. Sanders ◽  
Stephen Shaw ◽  
...  
1987 ◽  
Vol 17 (7) ◽  
pp. 1015-1020 ◽  
Author(s):  
William A. Sewell ◽  
Marion H. Brown ◽  
Michael J. Owen ◽  
Pamela J. Fink ◽  
Christine A. Kozak ◽  
...  

Author(s):  
Alan M. Krensky ◽  
Steven J. Mentzer ◽  
Julia L. Greenstein ◽  
Mary Crimmins ◽  
Carol Clayberger ◽  
...  

2019 ◽  
Author(s):  
Eleanor M Denham ◽  
Michael I Barton ◽  
Susannah M Black ◽  
Marcus J Bridge ◽  
Ben de Wet ◽  
...  

AbstractDose-response experiments are a mainstay of receptor biology studies and can reveal valuable insights into receptor function. Such studies of receptors that bind cell surface ligands are currently limited by the difficulty in manipulating the surface density of ligands at a cell-cell interface. Here we describe a generic cell surface ligand system that allows precise manipulation of cell surface ligand densities over several orders of magnitude. We validate the system for a range of immunoreceptors, including the T cell receptor (TCR), and show that this generic ligand stimulates via the TCR at a similar surface density as its native ligand. This system allows the effect of surface density, valency, dimensions, and affinity of the ligand to be manipulated. It can be readily extended to other receptor-cell surface ligand interactions, and will facilitate investigation into the activation of, and signal integration between, cell surface receptors.


2000 ◽  
Vol 355 (1395) ◽  
pp. 361-362 ◽  
Author(s):  
Peter C. Doherty

The school of thought that owes allegiance to Ludwig Wittgenstein teaches that language conditions perceptions. When we use the term ‘cytotoxic T lymphocyte’ or ‘helper Tcell’ we tend to orientate our own thinking processes, and those of listeners or readers, down particular paths. Part of the problem is that we are often describing cell populations by functions that may either be a property of only a proportion of those that are being assayed, or are simply inferred from the expression of various cell–surface markers. The consequence can be a measure of confusion that might be avoided if we could communicate with greater clarity. Is it possible to achieve a better terminology that will be accepted generally? The following are some examples of why there may be some value in thinking about this.


2006 ◽  
Vol 50 (4) ◽  
pp. 315-325 ◽  
Author(s):  
Mami Kishimoto ◽  
Atsutoshi Yoshimura ◽  
Mariko Naito ◽  
Kuniaki Okamoto ◽  
Kenji Yamamoto ◽  
...  
Keyword(s):  
A Cell ◽  

PLoS Biology ◽  
2019 ◽  
Vol 17 (12) ◽  
pp. e3000549 ◽  
Author(s):  
Eleanor M. Denham ◽  
Michael I. Barton ◽  
Susannah M. Black ◽  
Marcus J. Bridge ◽  
Ben de Wet ◽  
...  

2015 ◽  
pp. 21-24
Author(s):  
J. L. Maryanski ◽  
H. R. MacDonald ◽  
R. K. Lees ◽  
B. Sordat ◽  
J. -C. Cerottini

1993 ◽  
Vol 78 (4) ◽  
pp. 619-629
Author(s):  
Toshiki Yamasaki ◽  
George Klein ◽  
Hans-Gustaf Ljunggren ◽  
Klas Kärre ◽  
Kouzo Moritake ◽  
...  

✓ The role of N-myc, c-src, and major histocompatibility complex (MHC, H-2 in the mouse) class I antigen gene expressions in dimethyl sulfoxide (DMSO)-induced differentiation and intracerebral tumorigenicity was examined using a mouse MNB85 neuroblastoma cell line. A fluorescence-activated cell sorter disclosed cell-surface MHC enhancement by DMSO, causing an increase in cytotoxic T-lymphocyte sensitivity. Southern blot analysis verified a single copy of the proto-oncogenes and MHC deoxyribonucleic acids in both untreated and DMSO-treated MNB85 cells. Northern blot analysis indicated that DMSO treatment induced a decrease in N-myc and an increase in c-src and MHC messenger ribonucleic acids. Nuclear run-off transcription assay revealed down-regulation of N-myc at a posttranscriptional level, contrasted with primary up-regulation of c-src at a transcriptional level. Immunoprecipitation after treatment with enzyme endo-beta-N-acetyl-glycoseamidase H proved that the terminal glycosylation of MHC heavy-chain gene products normally occurs in the Golgi apparatus of MNB85 cells. Intracerebral tumorigenicity assay showed that cells highly MHC-expressed by DMSO were less tumorigenic than untreated cells in association with DMSO-augmented cytotoxic T-lymphocyte susceptibility. These results suggest that proto-oncogenes may be linked to cellular differentiation, while cell-surface MHC gene expression influences intracerebral immunosurveillance.


1987 ◽  
Vol 165 (3) ◽  
pp. 664-676 ◽  
Author(s):  
M L Plunkett ◽  
M E Sanders ◽  
P Selvaraj ◽  
M L Dustin ◽  
T A Springer

CD2, also known as LFA-2, T11, and the E rosette receptor, is a T lymphocyte surface protein functionally important in adhesion to target cells and T cell triggering. LFA-3 is a widely distributed cell surface protein that functions in adhesion on target cells. We find that LFA-3 is expressed on human E, and that CD2 is a receptor for LFA-3 that mediates T cell adhesion to human E. Pretreatment of T lymphocytes with CD2 mAb or of E with LFA-3 mAb inhibits rosetting. Purified CD2 molecules bind to human E and inhibit rosetting. 125I-CD2 binding to E is inhibited by LFA-3 mAb; reciprocally, binding of LFA-3 mAb to human E is inhibited by pretreatment with purified CD2. Higher concentrations of CD2 aggregate human E; aggregation is inhibited by mAb to LFA-3.


Sign in / Sign up

Export Citation Format

Share Document